Moir-Ai offers an AI-powered platform that aggregates preclinical data and applies multi-objective machine‑learning models to predict efficacy, safety, pharmacokinetics, and clinical translatability of drug candidates. The system ranks and visualizes compounds, enabling pharmaceutical, biotech, and academic researchers to prioritize candidates with higher chances of IND success while reducing reliance on animal testing.
Funding
Funding not disclosed
Founders
Product
Problem
Drug development suffers from high attrition rates, lengthy timelines, and a heavy reliance on animal testing, which often fails to predict human therapeutic outcomes accurately.
Solution
Moir-Ai provides an AI-driven, multi-objective optimization platform that integrates into existing pharmaceutical, biotech, and academic R&D workflows. The platform aggregates preclinical data, applies machine-learning models, and generates predictive assessments of therapeutic properties and translational performance. By delivering a unified, data-driven view of candidate profiles, it helps researchers prioritize compounds with higher likelihood of clinical success and reduces reliance on animal studies. The system supports simultaneous optimization across key objectives such as efficacy, safety, and pharmacokinetics, enabling more informed IND-enabling decisions. Ultimately, Moir-Ai aims to accelerate the translational phase of drug development while adhering to modern ethical standards.
Target Audience
Primary users are pharmaceutical companies, biotech firms, and academic research groups engaged in preclinical drug discovery and seeking data-driven support for IND-enabling decisions.
Features
- Integrated data pipeline that consolidates diverse preclinical datasets (e.g., in‑vitro assays, animal studies, omics) for unified analysis
- Multi-objective machine-learning models that predict efficacy, safety, pharmacokinetics, and other therapeutic endpoints simultaneously
- Comparative ranking of drug candidates based on optimized therapeutic profiles and projected clinical translatability
- Scenario simulation tools allowing users to explore how modifications to molecular structure or dosing affect multiple objectives
- Dashboard visualizations that present holistic candidate assessments and risk metrics for IND decision-making
- API and workflow connectors for seamless incorporation into existing pharma and biotech R&D processes